Saturday, December 6, 2025
ADVT 
Health

Diabetes Canada calls for federal government to reset pharmacare program

Darpan News Desk The Canadian Press, 30 Jul, 2025 10:20 AM
  • Diabetes Canada calls for federal government to reset pharmacare program

Advocates for people with diabetes want the federal government to restructure what they see as a flawed pharmacare program.

Glenn Thibeault, executive director of government affairs with Diabetes Canada, says the new government has an opportunity to make improvements.

The previous Trudeau government budgeted $1.5 billion over five years for the first phase of pharmacare, which covers the cost of some diabetes medications and contraceptives for patients. 

That government signed deals with B.C., P.E.I., Manitoba and Yukon that account for more than 60 per cent of the money that's set aside. 

The Carney government is not committing to signing the remaining nine funding deals, saying that it's working with the provinces and territories to support them.

Thibeault says Diabetes Canada wants to see more medications covered and says future deals could target coverage for people who don't have private insurance.

Picture Courtesy: AP Photo/Joerg Sarbach, File

MORE Health ARTICLES

UN: 870K measles cases in 2019, highest number in 23 years

UN: 870K measles cases in 2019, highest number in 23 years
To prevent measles outbreaks, WHO estimates about 95% of the population must be immunized.

UN: 870K measles cases in 2019, highest number in 23 years

News of potential COVID vaccine 'encouraging': PM

News of potential COVID vaccine 'encouraging': PM
The prime minister says news from Pfizer today that one of its vaccine candidates appears very effective in clinical trials is "very encouraging" but won't help anyone who catches the virus in the meantime.

News of potential COVID vaccine 'encouraging': PM

FDA panel urges rejection of experimental Alzheimer's drug

FDA panel urges rejection of experimental Alzheimer's drug
Friday’s meeting follows months of skepticism about the drug, developed by Cambridge, Massachusetts-based Biogen Inc. and Japan’s Eisai Co.

FDA panel urges rejection of experimental Alzheimer's drug

Health Canada approves first HIV self-test

Health Canada approves first HIV self-test
Health Canada granted a medical device licence on Monday to a one-minute, finger-prick blood test manufactured by Richmond, B.C.-based bioLytical Laboratories.

Health Canada approves first HIV self-test

Cost of cancer drugs triples in Canada

Cost of cancer drugs triples in Canada
The Patented Medicine Prices Review Board has released data showing cancer medications account for about 15 per cent of all spending on pharmaceuticals.

Cost of cancer drugs triples in Canada

Health panel proposes colon cancer tests start at 45, not 50

Health panel proposes colon cancer tests start at 45, not 50
While overall, colon cancer rates have been declining, the draft guidelines issued Tuesday by the U.S. Preventive Services Task Force reflect a growing concern about rising rates in people under the age of 50.

Health panel proposes colon cancer tests start at 45, not 50